Class information for:
Level 1: CARANE DERIVATIVES//AII RECEPTORS//BLOOD PLATELET

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
24688 254 28.9 54%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
202 20434 CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CARANE DERIVATIVES Author keyword 4 67% 2% 4
2 AII RECEPTORS Author keyword 1 50% 0% 1
3 BLOOD PLATELET Author keyword 1 50% 0% 1
4 ISRAPIDINE Author keyword 1 50% 0% 1
5 PERINDOPRIL THERAPY Author keyword 1 50% 0% 1
6 PLATELET AGGREGATION INHIBITION Author keyword 1 50% 0% 1
7 PLATELET ANGIOTENSIN II RECEPTORS Author keyword 1 50% 0% 1
8 HEMOSTATIC FACTOR Author keyword 0 25% 0% 1
9 HLTH SCI CLIN PHARMACOL Address 0 25% 0% 1
10 PAVILLON ST FRANCOIS ASSISE Address 0 25% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 CARANE DERIVATIVES 4 67% 2% 4 Search CARANE+DERIVATIVES Search CARANE+DERIVATIVES
2 AII RECEPTORS 1 50% 0% 1 Search AII+RECEPTORS Search AII+RECEPTORS
3 BLOOD PLATELET 1 50% 0% 1 Search BLOOD++PLATELET Search BLOOD++PLATELET
4 ISRAPIDINE 1 50% 0% 1 Search ISRAPIDINE Search ISRAPIDINE
5 PERINDOPRIL THERAPY 1 50% 0% 1 Search PERINDOPRIL+THERAPY Search PERINDOPRIL+THERAPY
6 PLATELET AGGREGATION INHIBITION 1 50% 0% 1 Search PLATELET+AGGREGATION++INHIBITION Search PLATELET+AGGREGATION++INHIBITION
7 PLATELET ANGIOTENSIN II RECEPTORS 1 50% 0% 1 Search PLATELET+ANGIOTENSIN+II+RECEPTORS Search PLATELET+ANGIOTENSIN+II+RECEPTORS
8 HEMOSTATIC FACTOR 0 25% 0% 1 Search HEMOSTATIC+FACTOR Search HEMOSTATIC+FACTOR
9 HEMOSTASIS PARAMETERS 0 20% 0% 1 Search HEMOSTASIS+PARAMETERS Search HEMOSTASIS+PARAMETERS
10 REDUCED RENAL MASS HYPERTENSION 0 20% 0% 1 Search REDUCED+RENAL+MASS+HYPERTENSION Search REDUCED+RENAL+MASS+HYPERTENSION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PLATELET ALPHA2 ADRENOCEPTOR ALTERATIONS 1 50% 0% 1
2 OUTCOMES TRIAL ASCOT 1 22% 1% 2
3 CATECHOLAMINE MEASUREMENTS 0 33% 0% 1
4 SERINE BASE EXCHANGE 0 33% 0% 1
5 PLASMA BETA THROMBOGLOBULIN 0 15% 1% 2
6 BLOOD FLOW CYTOMETRY 0 20% 0% 1
7 PIG PLATELETS 0 20% 0% 1
8 PLASMA CYCLIC AMP 0 20% 0% 1
9 RENAL ARTERIAL DISEASE 0 20% 0% 1
10 INTRACELLULAR MESSENGER 0 10% 1% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Pharmacological modulation of platelet function in hypertension 2003 42 90 23%
ACTIVATION OF XENOBIOTICS INTO FREE-RADICALS BY PROSTAGLANDIN-H-SYNTHASE AND BY RAT-LIVER MICROSOMES 1995 0 1 100%
Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine 1997 126 77 10%
DEFINITION OF PLATELET-DERIVED HISTAMINE RELEASING-FACTOR (PDHRF) AND HISTAMINERGIC RECEPTORS MODULATING PLATELET-AGGREGATION 1991 0 4 75%
The prothrombotic state in hypertension and the effects of antihypertensive treatment 2003 39 176 11%
Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors 2006 19 108 9%
Platelet function and fibrinolytic activity in borderline and mild hypertension - The influence of age, exercise, smoking and antihypertensive therapy 2002 1 134 16%
PLATELET BETA-ADRENOCEPTOR FUNCTION - EXPERIMENTAL AND CLINICAL-STUDIES WITH SPECIAL REFERENCE TO AGE AND STRESS 1991 3 69 28%
THE HYPERTENSION CORONARY HEART-DISEASE DILEMMA - THE CATECHOLAMINE BLOOD-PLATELET CONNECTION 1989 21 84 8%
Pharmacological role of the atenolol/nifedipine combination in hypertensive patients 1998 3 12 8%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 HLTH SCI CLIN PHARMACOL 0 25% 0.4% 1
2 PAVILLON ST FRANCOIS ASSISE 0 25% 0.4% 1
3 PROP MED 2 0 25% 0.4% 1
4 REG PHYSICOCHEM ANAL 0 25% 0.4% 1
5 CARDIOL COMPLEX 0 20% 0.4% 1
6 IRCCS INTERNAL MED THER EUT 0 17% 0.4% 1
7 UNIDAD CARDIOCIRCULAC 0 17% 0.4% 1
8 REG PHYSIOCHEM ANAL STRUCT 0 13% 0.4% 1
9 UNIDAD BIOL PATOL CELULAR 0 11% 0.4% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000174198 PLATELET PMN INTERACTION//ATHLETIC HORSE//B TG
2 0.0000153664 PLASMA RECALCIFICATION//TAIL BLEEDING TIME//RAT PLATELET
3 0.0000147445 HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2
4 0.0000145187 COAGULATION ABNORMALITY//D L LYSINACETYLSALICYLATE//SECT CLIN GERONTOL VASC MED
5 0.0000124026 CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY//PREECLAMPSIA PREVENTION//LOW DOSE ASPIRIN
6 0.0000117008 ABT MED FOR//CARDIOSELECTIVE BETA RECEPTOR ANTAGONIST//PAREXEL GMBH
7 0.0000090950 PATOL VASC NEFROL EXPT//VASC RENAL PATHOL//MED ALFREDO LANARI
8 0.0000086783 MEAN PLATELET VOLUME//PLATELET DISTRIBUTION WIDTH//PLATELET INDICES
9 0.0000083508 ENDOTHELAEMIA//INTERDISCIPLINARY ONCOLEXPT THER EUT PROGR//ENDOTHELEMIA
10 0.0000083458 NONMODULATION//HYPERTENSION NONMODULATING//EXTREME NORTH